You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Hypertensive diseases and eclampsia

Myers, Jenny E.; Baker, Philip N.

Current Opinion in Obstetrics & Gynecology:
Maternal-fetal medicine
Abstract

Worldwide, pre-eclampsia and eclampsia contribute to the death of a pregnant woman every 3 min. In the UK in recent decades, hypertensive disorders of pregnancy have remained one of the leading causes of both maternal and perinatal morbidity and mortality. The management of pregnancies complicated by hypertension has not significantly altered for many years, possibly as a result of little progress being made in our understanding of the condition. New insights, however, have recently been gained into the pathophysiology of pre-eclampsia. These have yet to be translated into new interventions or to make any impact on clinical management of these pregnancies. This review will therefore focus on recent advances relating to research into the aetiology and pathogenesis of pre-eclampsia, but will conclude with a brief update on current therapeutic strategies.

Author Information

Maternal and Fetal Health Research Centre, St Mary's Hospital, Manchester, UK

Correspondence to J.E. Myers, Maternal and Fetal Health Research Centre, St Mary's Hospital, Hatherscope Road, Manchester M13 0TH, UK. Tel: +44 161 276 5459; Fax: +44 161 766 134; e-mail: jenny.myers@man.ac.uk

Abbreviation VEGF: vascular endothelial growth factor

© 2002 Lippincott Williams & Wilkins, Inc.